<table sstyle="width:80%" align="center" border=1>
<tr>
<th>mv</th>
<th>dw</th>
<th>HMMCrowd</th>
</tr>
<tr>
<td width=33%>
[180, 202] General surgical patients including those undergoing noncardiac thoracic and pelvic operations who were identified at moderate to high risk for postop DVT<br>[238, 244] Eight hundred and eighty eight patients<br></td>
<td width=33%>
[17, 22] postoperative deep venous thrombosis.<br>[27, 30] deep venous thrombosis<br>[146, 148] United States<br>[180, 202] General surgical patients including those undergoing noncardiac thoracic and pelvic operations who were identified at moderate to high risk for postop DVT<br>[238, 244] Eight hundred and eighty eight patients<br>[250, 251] 744<br></td>
<td width=33%>
[17, 22] postoperative deep venous thrombosis.<br>[26, 33] postoperative deep venous thrombosis (DVT)<br>[44, 54] stasis, a hypercoagulable state and venous endothelial damage.<br>[146, 148] United States<br>[180, 205] General surgical patients including those undergoing noncardiac thoracic and pelvic operations who were identified at moderate to high risk for postop DVT were included.<br>[238, 259] Eight hundred and eighty eight patients were entered into this trial and 744 (85%) completed the study.<br></td>
</tr>
